Cited by 751Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System

Mackie, K.·2005·Handbook of Experimental Pharmacology

DOI 10.1007/3-540-26573-2_10

Open this paper in CoChat — free account

Abstract

CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compounds. This G protein-coupled receptor has a characteristic distribution in the nervous system: It is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum--a distribution that corresponds to the most prominent behavioral effects of cannabis. In addition, this distribution helps to predict neurological and psychological maladies for which manipulation of the endocannabinoid system might be beneficial. CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses. While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 years, there is still more to learn. Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the determination of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.

Integrity signals

Registry

Crossref · 10.1007/3-540-26573-2_10

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Interneurons of the hippocampus
Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4 · Cited by 3,478
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Self-citation
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citation
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ 1 Opioid Receptor Mechanism
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085

Flagged first, then by citations

Show all 103 references

Research works printed but not linked: 1

Riegal AC, Williams JT, Lupica CR (2003) Cananbionid CB1 receptors inhibit GABA-Bmediated synaptic currents in midbrain dopaminergic neurons. Soc Neurosci Abstr 33:462466

Sorted by citations

Items 201–300 of 751

The role of the endocannabinoid system in eating disorders
Marco, E. M., Romero‐Zerbo, S., Viveros, M., & Bermúdez‐Silva, F. J. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328356c3c9 · Cited by 46
The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions
Viveros, M., Marco, E. M., Llorente, R., & Lamota, L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28fb4 · Cited by 44
NMP-7 Inhibits Chronic Inflammatory and Neuropathic Pain via Block of Cav3.2 T-type Calcium Channels and Activation of CB2 Receptors
Berger, N. D., Gadotti, V. M., Petrov, R. R., Chapman, K., Diaz, P., & Zamponi, G. W. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-77 · Cited by 43
Cannabinoids-Promising Antimicrobial Drugs or Intoxicants with Benefits?
Klahn, P. (2020) · Antibiotics · doi:10.3390/antibiotics9060297 · Cited by 43
Endocannabinoids exert CB 1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein
Xu, C., Hermes, D. J., Nwanguma, B., Jacobs, I. R., Mackie, K., Mukhopadhyay, S., Lichtman, A. H., Ignatowska-Jankowska, B. M., & Fitting, S. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.07.003 · Cited by 43
Self-citation
Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers
Bian, Y., Jing, Y., Wang, L., Ma, S., Jun, J. J., & Xie, X. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00182 · Cited by 43
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure
Llorente‐Berzal, A., Assis, M. A., Rubino, T., Zamberletti, E., Marco, E. M., Parolaro, D., Ambrosio, E., & Viveros, M. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.05.001 · Cited by 42
New Natural Noncannabinoid Ligands for Cannabinoid Type-2 (CB2) Receptors
Gertsch, J., Raduner, S., & Altmann, K. (2006) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890600942674 · Cited by 42
Endocannabinoid Regulation of Neuroendocrine Systems
Tasker, J. G., Chen, C., Fisher, M. O., Fu, X., Rainville, J. R., & Weiss, G. L. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.09.003 · Cited by 41
Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
Ratano, P., Palmery, M., Trezza, V., & Campolongo, P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00200 · Cited by 41
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
Scherma, M., Masia, P., Deidda, M. L., Fratta, W., Tanda, G., & Fadda, P. (2018) · Medicines · doi:10.3390/medicines5040107 · Cited by 43
Communication and social interaction in the cannabinoid‐type 1 receptor null mouse: Implications for autism spectrum disorder
Fyke, W., Premoli, M., Echeverry‐Alzate, V., López‐Moreno, J. A., Lemaire, V., Crusio, W. E., Marsicano, G., Wöhr, M., & Pietropaolo, S. (2021) · Autism Research · doi:10.1002/aur.2562 · Cited by 43
Resilience to meet the challenge of addiction: psychobiology and clinical considerations
Alim, T. N. (2012) · Alcohol research · doi:10.35946/arcr.v34.4.14 · Cited by 42
Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information
Ranganathan, M., Radhakrishnan, R., Addy, P. H., Martin, A. M. S., Williams, A. H., Carbuto, M., Elander, J., Pittman, B. P., Sewell, R. A., Skosnik, P. D., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.019 · Cited by 40
CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurr1 signal pathways
Han, Q.-W., Shao, Q.-H., Wang, X., Ma, K., Chen, N., & Yuan, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00853-8 · Cited by 40
Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference
Hashemizadeh, S., Sardari, M., & Rezayof, A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.010 · Cited by 39
Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches
Jin, H., Lee, K.-W., Song, M.-J., Hyeon, Y.-J., Hwang, J.-Y., Jang, C., Ahn, J., Jeon, S.-H., Kim, H. U., Kim, Y., et al. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.039 · Cited by 39
Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse
Skike, C. E. V., Maggio, S. E., Reynolds, A. R., Casey, E. M., Bardo, M. T., Dwoskin, L. P., Prendergast, M., & Nixon, K. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.004 · Cited by 43
Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
Capozzi, A., Caissutti, D., Mattei, V., Gado, F., Martellucci, S., Longo, A., Recalchi, S., Manganelli, V., Riitano, G., Garofalo, T., et al. (2021) · Molecules · doi:10.3390/molecules27010064 · Cited by 38
Targeting the Limbic System: Insights into Its Involvement in Tinnitus
Singh, A., Smith, P. F., & Zheng, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129889 · Cited by 40
Mechanisms of cannabinoid tolerance
Piscura, M. K., Henderson, A. N., Barnes, R. C., Mitra, S., Guindon, J., & Morgan, D. J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115665 · Cited by 40
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity
Conzelmann, A., Reif, A., Jacob, C., Weyers, P., Lesch, K., Lutz, B., & Pauli, P. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2785-y · Cited by 41
PET imaging of cannabinoid type 2 receptors with [ 11 C]A-836339 did not evidence changes following neuroinflammation in rats
Pottier, G., Gómez‐Vallejo, V., Padró, D., Boisgard, R., Dollé, F., Llop, J., Winkeler, A., & Martín, A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16685105 · Cited by 38
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls
Rabin, R. A., Barr, M. S., Goodman, M. S., Herman, Y., Zakzanis, K. K., Kish, S. J., Michael Kiang, A., Remington, G. J., & George, T. P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.85 · Cited by 38
Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome
Hirsch, S., & Tam, J. (2019) · Toxins · doi:10.3390/toxins11050275 · Cited by 38
Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice
Zhang, H., Shen, H., Gao, M., Ma, Z., Hempel, B. J., Bi, G., Gardner, E. L., Wu, J., & Xi, Z. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108538 · Cited by 38
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Martini, S., Gemma, A., Ferrari, M., Cosentino, M., & Marino, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043125 · Cited by 39
Increase of cannabinoid CB1 receptor density in the hippocampus of streptozotocin-induced diabetic rats
Duarte, J. M. N., Nogueira, C., Mackie, K., Oliveira, C. R., Cunha, R. A., & Köfalvi, A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.11.013 · Cited by 38
Self-citation
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
Ruggiero, R. N., Rossignoli, M. T., Ross, J. B. D., Hallak, J. E. C., Leite, J. P., & Bueno-Júnior, L. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00399 · Cited by 39
Cannabinoids and the Microbiota–Gut–Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders
Karoly, H. C., Mueller, R. L., Bidwell, L. C., & Hutchison, K. E. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14256 · Cited by 37
Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry
Jelsing, J., Larsen, P. J., & Vrang, N. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.051 · Cited by 37
Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism
Alén, F., Crespo, I., Ramírez-López, M. T., Jagerovic, N., Goya, P., de Fonseca, F. R., de Heras, R. G., & Orío, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060918 · Cited by 36
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies
Xing, G., Carlton, J. R., Jiang, X., Wen, J., Jia, M., & Li, H. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00161 · Cited by 39
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence
Scherma, M., Fattore, L., Castelli, M. P., Fratta, W., & Fadda, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990429 · Cited by 36
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Martínez‐Pinilla, E., Aguinaga, D., Navarro, G., Rico, A. J., Oyarzábal, J., Sánchez-Arias, J. A., Lanciego, J. L., & Franco, R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1495-4 · Cited by 36
The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease
Han, Q.-W., Yuan, Y., & Chen, N. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109745 · Cited by 37
Stress and drug abuse-related disorders: The promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathway
Tomaselli, G., & Vallée, M. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100789 · Cited by 41
Cannabidiol as a Treatment for Mood Disorders: A Systematic Review: Le cannabidiol comme traitement des troubles de l’humeur: une revue systématique
Pinto, J. V., Saraf, G., Frysch, C., Vigo, D., Keramatian, K., Chakrabarty, T., Lam, R. W. M., Kauer‐Sant’Anna, M., & Yatham, L. N. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719895195 · Cited by 38
Synaptic changes induced by cannabinoid drugs and cannabis use disorder
Augustin, S. M., & Lovinger, D. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105670 · Cited by 38
Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?
Weresa, J., Pędzińska‐Betiuk, A., Mińczuk, K., Malinowska, B., & Schlicker, E. (2022) · Cells · doi:10.3390/cells11071142 · Cited by 36
The Basic Science of Cannabinoids
Sideris, A., Lauzadis, J., & Kaczocha, M. (2023) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006472 · Cited by 38
Cannabis sativaand the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation
Farrimond, J. A., Mercier, M. S., Whalley, B. J., & Williams, C. M. (2011) · Phytotherapy Research · doi:10.1002/ptr.3375 · Cited by 37
Cannabinoid-Opioid Interactions in Drug Discrimination and Self-Administration: Effect of Maternal, Postnatal, Adolescent and Adult Exposure to the Drugs
Spano, M., Fadda, P., Fratta, W., & Fattore, L. (2010) · Current Drug Targets · doi:10.2174/138945010790980295 · Cited by 36
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease
Izzo, A. A., Muccioli, G. G., Ruggieri, M. R., & Schicho, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_15 · Cited by 35
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas
Marco, E. M., Rubino, T., Adriani, W., Viveros, M., Parolaro, D., & Laviola, G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.12.037 · Cited by 35
Tobacco may mask poorer episodic memory among young adult cannabis users.
Schuster, R. M., Crane, N. A., Mermelstein, R. J., & González, R. (2015) · Neuropsychology · doi:10.1037/neu0000173 · Cited by 35
Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
Vera, D. M., Rosell‐Valle, C., López-Gambero, A. J., Navarro, J. A., Zambrana-Infantes, E. N., Rivera, P., Santín, L. J., Suárez, J., & de Fonseca, F. R. (2020) · Biology · doi:10.3390/biology9110377 · Cited by 35
Cannabinoid Receptor 1 Gene by Cannabis Use Interaction on CB1 Receptor Density
Ketcherside, A., Noble, L. J., McIntyre, C. K., & Filbey, F. M. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0007 · Cited by 35
Resting state functional connectivity in the default mode network: Relationships between cannabis use, gender, and cognition in adolescents and young adults
Ritchay, M. M., Huggins, A. A., Wallace, A. L., Larson, C. L., & Lisdahl, K. M. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102664 · Cited by 36
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB1 receptor antagonists
Kirilly, E., Hunyady, L., & Bagdy, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0900-1 · Cited by 34
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Fernández‐Ruíz, J., Galve‐Roperh, I., Sagredo, O., & Guzmán, M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.01.013 · Cited by 35
A systematic review of cannabidiol trials in neurodevelopmental disorders
Parrella, N.-F., Hill, A. T., Enticott, P. G., Barhoun, P., Bower, I. S., & Ford, T. C. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173607 · Cited by 34
Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease
Preteroti, M., Wilson, E. T., Eidelman, D. H., & Baglole, C. J. (2023) · Respiratory Research · doi:10.1186/s12931-023-02399-1 · Cited by 34
Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory.
Doss, M. K., Samaha, J., Barrett, F. S., Griffiths, R. R., de Wit, H., Gallo, D. A., & Koen, J. D. (2023) · Psychological Review · doi:10.1037/rev0000455 · Cited by 33
Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect
Gorka, S. M., Phan, K. L., Lyons, M., Mori, S., Angstadt, M., & Rabinak, C. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.359 · Cited by 35
The potential role of cannabinoids in epilepsy treatment
Caro, C. D., Leo, A., Citraro, R., Sarro, C. D., Russo, R., Calignano, A., & Russo, E. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1373019 · Cited by 36
∆9‑tetrahydrocannabinol inhibits epithelial‑mesenchymal transition and metastasis by targeting matrix metalloproteinase‑9 in endometrial cancer
Zhang, Y., Wei, Z., Shen, K., & Shen, W. (2018) · Oncology Letters · doi:10.3892/ol.2018.8407 · Cited by 33
Therapeutic potential of cannabinoids in combination cancer therapy
Malhotra, P., Casari, I., & Falasca, M. (2021) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100774 · Cited by 33
Cannabinoids, reward processing, and psychosis
Gunasekera, B., Diederen, K. M. J., & Bhattacharyya, S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05801-2 · Cited by 35
“Photo-Rimonabant”: Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar “ Cis -On” CB 1 R Antagonist
Rodríguez‐Soacha, D. A., Fender, J., Ramírez, Y. A., Collado, J. A., Muñóz, E., Maitra, R., Sotriffer, C., Lorenz, K., & Decker, M. W. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00086 · Cited by 33
Endocannabinoid Modulation of Dopaminergic Motor Circuits
Morera‐Herreras, T., Miguélez, C., Aristieta, A., Ruíz-Ortega, J. Á., & Ugedo, L. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00110 · Cited by 35
Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-d-aspartate receptors
Alén, F., Santos, Á., Moreno‐Sanz, G., González‐Cuevas, G., Giné, E., Franco-Ruiz, L., Navarro, M. A., & López‐Moreno, J. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.002 · Cited by 33
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse
Xing, G., Carlton, J. R., Zhang, L., Jiang, X., Fullerton, C. S., Li, H., & Ursano, R. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.013 · Cited by 35
Verbal Memory Performance and Reduced Cortical Thickness of Brain Regions Along the Uncinate Fasciculus in Young Adult Cannabis Users
Levar, N., Francis, A., Smith, M. J., Ho, W. C., & Gilman, J. M. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0030 · Cited by 33
Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans
Ballard, M. E., Gallo, D. A., & de Wit, H. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2924-5 · Cited by 32
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington's disease
Pietropaolo, S., Bellocchio, L., Ruiz-Calvo, A., Cabanas, M., Du, Z., Guzmán, M., Garret, M., & Cho, Y. H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.021 · Cited by 34
Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
Zádor, F., Nagy-Grócz, G., Kékesi, G., Dvorácskó, S., Szűcs, E., Tömböly, C., Horváth, G., Benyhe, S., & Vécsei, L. (2019) · Molecules · doi:10.3390/molecules24203709 · Cited by 33
The implications of late-life cannabis use on brain health: A mapping review and implications for future research
Weinstein, G., & Sznitman, S. R. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101041 · Cited by 33
Cannabinoid receptor activation acutely increases synaptic vesicle numbers by activating synapsins in human synapses
Patzke, C., Dai, J., Brockmann, M. M., Sun, Z., Fenske, P., Rosenmund, C., & Südhof, T. C. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01095-0 · Cited by 33
Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries
Bian, Y., & Xie, X. (2022) · Cells · doi:10.3390/cells11050915 · Cited by 32
Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat.
Shujaa, N., Zádori, Z., Rónai, A. Z., Barna, I., Mergl, Z., Mozes, M., & Gyires, K. (2009) · PubMed · Cited by 32
Cannabinoid receptor as a potential therapeutic target for Parkinson’s Disease
Baul, H. S., Manikandan, C., & Sen, D. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.01.016 · Cited by 32
Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions
Ferraro, L., Tomasini, M. C., Beggiato, S., Gaetani, S., Cassano, T., Cuomo, V., Amoroso, S., Tanganelli, S., & Antonelli, T. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0230-0 · Cited by 32
Dorsal hippocampal cannabinoid CB1 receptors mediate the interactive effects of nicotine and ethanol on passive avoidance learning in mice
Alijanpour, S., Rezayof, A., & Zarrindast, M. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00387.x · Cited by 31
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report
Bergamaschi, M. M., Queiróz, R. H. C., Chagas, M. H. N., Linares, I. M. P., Arrais, K. C., de Oliveira, D. C. G., Queiroz, M. E. C., Nardi, A. E., Huestis, M. A., Hallak, J. E. C., et al. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2374 · Cited by 32
Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors
Laksmidewi, A. A. A. P., & Soejitno, A. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02326-y · Cited by 35
Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
Dasram, M. H., Walker, R. B., & Khamanga, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113223 · Cited by 31
Part II: Strain- and sex-specific effects of adolescent exposure to THC on adult brain and behaviour: Variants of learning, anxiety and volumetric estimates
Keeley, R. J., Trow, J., Bye, C., & McDonald, R. J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.001 · Cited by 31
In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission
Degroot, A., & Nomikos, G. G. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.001 · Cited by 31
The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond
Rahman, S., Ayyagari, A., Dutta, D., Kumar, V., Kim, J., Jan, A. T., & Minakshi, R. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.01.005 · Cited by 31
Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29
A longitudinal study of the impact of marijuana on adult memory function: Prenatal, adolescent, and young adult exposures
Willford, J. A., Goldschmidt, L., Genna, N. M. D., Day, N. L., & Richardson, G. A. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106958 · Cited by 32
Identification of cannabinoid type 1 receptor in dog hair follicles
Mercati, F., Dall’Aglio, C., Pascucci, L., Boiti, C., & Ceccarelli, P. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2011.01.003 · Cited by 29
Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission
Morsch, M., Protti, D. A., Cheng, D., Braet, F., Chung, R. S., Reddel, S., & Phillips, W. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-22888-4 · Cited by 29
Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats
Carnevali, L., Statello, R., Vacondio, F., Ferlenghi, F., Spadoni, G., Rivara, S., Mor, M., & Sgoifo, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.119 · Cited by 30
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Cortez, I. L., da Silva, N. R., Guimarães, F. S., & Gomes, F. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587154 · Cited by 29
Beneficial effect of a chronic treatment with rimonabant on pancreatic function and β-cell morphology in Zucker Fatty rats
Duvivier, V., Delafoy-Plasse, L., Delion, V., Lechevalier, P., Bail, J.-C. L., Guillot, E., Pruniaux, M., & Galzin, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.024 · Cited by 29
From Synaptic Physiology to Synaptic Pathology: The Enigma of α-Synuclein
Nordengen, K., & Morland, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020986 · Cited by 30
Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period
Rudenko, V., Rafiuddin, A., Leheste, J. R., & Friedman, L. K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.005 · Cited by 28
Sleep-Inducing Factors
García‐García, F., Acosta-Peña, E., Venebra-Muñoz, A., & Murillo‐Rodríguez, E. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709788921672 · Cited by 28
Endogenous antagonists of N‐methyl‐ d ‐aspartate receptor in schizophrenia
Jorratt, P., Höschl, C., & Ovsepian, S. V. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12244 · Cited by 28
Current review of hemp‐based medicines in dogs
Coelho, M. P. R. C., Leme, F. D. O. P., Moreira, F. A., Branco, S. E. M. T., Melo, M. M., & Melo, E. G. (2021) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.13016 · Cited by 30
Emotional, endocrine and brain anandamide response to social challenge in infant male rats
Marco, E. M., Scattoni, M. L., Rapino, C., Ceci, C., Chaves, N., Macrı̀, S., Maccarrone, M., & Laviola, G. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.04.004 · Cited by 28
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring
Ramírez-López, M. T., Arco, R., Decara, J. M., Vázquez, M., Blanco, R. N., Alén, F., Suárez, J., de Heras, R. G., & de Fonseca, F. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165432 · Cited by 27
Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment
Tapia, M., Dominguez, A. L., Zhang, W., del Puerto, A., Ciorraga, M., Benítez, M. J., Guaza, C., & Garrido, J. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00005 · Cited by 30
Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor
Qiao, C.-J., Ali, H. I., Ahn, K. H., Kolluru, S., Kendall, D. A., & Lu, D. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.044 · Cited by 26
Biomarkers of the Endocannabinoid System in Substance Use Disorders
Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Navarro, D., Lopez‐Picon, F. R., Morcuende, Á., Femenía, T., & Manzanares, J. (2022) · Biomolecules · doi:10.3390/biom12030396 · Cited by 26
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Soler‐Cedeño, O., & Xi, Z. (2022) · Cells · doi:10.3390/cells11203262 · Cited by 26
Contribution of limbic norepinephrine to cannabinoid-induced aversion
Carvalho, A. F., Reyes, A.-R. S., Sterling, R. C., Unterwald, E. M., & Bockstaele, E. J. V. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1923-7 · Cited by 26
Cannabinoid CB1 Receptors Mediate the Gastroprotective Effect of Neurotensin.
Hassanzadeh, P., & Arbabi, E. (2012) · Europe PMC (PubMed Central) · Cited by 26

Authors: Mackie, K.
Affiliations: University of Washington (US)
Corresponding author: Mackie, K.
ORCID: Mackie, K.
Venue: Handbook of Experimental Pharmacology
Publisher: Springer-Verlag
Published: 2005-12-23
Issue: 168
Pages: 299-325
DOI: 10.1007/3-540-26573-2_10
OpenAlex: W2149183149
Cited by: 744
References: 103
Citations by year: 2026: 28 · 2025: 38 · 2024: 47 · 2023: 56 · 2022: 59 · 2021: 69 · 2020: 48 · 2019: 52 · 2018: 40 · 2017: 37 · 2016: 33 · 2015: 31 · 2014: 26 · 2013: 27 · 2012: 32
FWCI: 26.30
Type: book chapter
Language: en
Open access: closed
Locations: Springer eBooks (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA00286, DA11322, R01DA011322, K02DA000286)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: CB1 receptor, cannabinoid receptors, endocannabinoid system, delta-9-tetrahydrocannabinol, G protein-coupled receptors, receptor distribution, central nervous system, peripheral nervous system, hippocampus, amygdala, cerebellum, basal ganglia, neurotransmission
MeSH terms: Animals, Autoradiography, Central Nervous System, Humans, Immunohistochemistry, In Situ Hybridization, Peripheral Nervous System, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks